JP2025515485A5 - - Google Patents
Info
- Publication number
- JP2025515485A5 JP2025515485A5 JP2024563560A JP2024563560A JP2025515485A5 JP 2025515485 A5 JP2025515485 A5 JP 2025515485A5 JP 2024563560 A JP2024563560 A JP 2024563560A JP 2024563560 A JP2024563560 A JP 2024563560A JP 2025515485 A5 JP2025515485 A5 JP 2025515485A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- amino acid
- acid sequence
- hvr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263336539P | 2022-04-29 | 2022-04-29 | |
| US63/336,539 | 2022-04-29 | ||
| PCT/US2023/066393 WO2023212719A1 (en) | 2022-04-29 | 2023-04-28 | Compositions and methods for treating ocular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515485A JP2025515485A (ja) | 2025-05-15 |
| JP2025515485A5 true JP2025515485A5 (enExample) | 2026-05-08 |
Family
ID=88519880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024563560A Pending JP2025515485A (ja) | 2022-04-29 | 2023-04-28 | 眼の疾患を治療するための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250313614A1 (enExample) |
| EP (1) | EP4518896A4 (enExample) |
| JP (1) | JP2025515485A (enExample) |
| KR (1) | KR20250006238A (enExample) |
| CN (1) | CN119136830A (enExample) |
| AU (1) | AU2023262202A1 (enExample) |
| CA (1) | CA3250843A1 (enExample) |
| IL (1) | IL316218A (enExample) |
| MX (1) | MX2024013326A (enExample) |
| WO (1) | WO2023212719A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025184235A1 (en) * | 2024-02-28 | 2025-09-04 | Onl Therapeutics, Inc. | Methods and compositions for treating glaucoma |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8148330B2 (en) * | 2005-12-09 | 2012-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Modulation of synaptic maintenance |
| DK1991275T3 (en) * | 2006-03-08 | 2014-12-08 | Archemix Llc | Complement aptamers AND ANTI-C5 AGENTS FOR USE IN THE TREATMENT OF EYE DISEASES |
| FI3380518T3 (fi) * | 2015-11-24 | 2026-05-29 | Annexon Inc | Antikomplementtitekijä-C1Q:n Fab-fragmentteja ja niiden käyttöjä |
| CN116782940A (zh) * | 2020-12-04 | 2023-09-19 | 安尼艾克松股份有限公司 | 用于治疗眼部疾病的组合物和方法 |
-
2023
- 2023-04-28 US US18/860,825 patent/US20250313614A1/en active Pending
- 2023-04-28 CN CN202380037102.8A patent/CN119136830A/zh active Pending
- 2023-04-28 WO PCT/US2023/066393 patent/WO2023212719A1/en not_active Ceased
- 2023-04-28 EP EP23797592.5A patent/EP4518896A4/en active Pending
- 2023-04-28 CA CA3250843A patent/CA3250843A1/en active Pending
- 2023-04-28 KR KR1020247039210A patent/KR20250006238A/ko active Pending
- 2023-04-28 AU AU2023262202A patent/AU2023262202A1/en active Pending
- 2023-04-28 IL IL316218A patent/IL316218A/en unknown
- 2023-04-28 JP JP2024563560A patent/JP2025515485A/ja active Pending
-
2024
- 2024-10-28 MX MX2024013326A patent/MX2024013326A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023551734A5 (enExample) | ||
| JP2023517236A5 (enExample) | ||
| JP2021535758A5 (enExample) | ||
| JP2023544407A5 (enExample) | ||
| JP2017534646A5 (enExample) | ||
| JP2018527887A5 (enExample) | ||
| RU2019134338A (ru) | Иммуноконъюгаты антитела к pd-1 с мутантом il-2 или с il-15 | |
| JP2022513420A5 (enExample) | ||
| JP2020503260A5 (enExample) | ||
| JP2024520666A5 (enExample) | ||
| JP2025501028A5 (enExample) | ||
| JP2023548064A5 (enExample) | ||
| JP2021534797A5 (enExample) | ||
| JP2024541680A5 (enExample) | ||
| JP2025503339A5 (enExample) | ||
| JP2017534645A5 (enExample) | ||
| JP2025503614A5 (enExample) | ||
| IL255552A (en) | Treatment of multiple myeloma | |
| JP2018533569A5 (enExample) | ||
| JP2024534602A5 (enExample) | ||
| JP2022526826A (ja) | Ｈｉｖ感染症の処置のためのクロスオーバー二重可変ドメイン（ｃｏｄｖ）フォーマットを使用した三重特異性および／または三価結合性タンパク質 | |
| JP2024530325A5 (enExample) | ||
| JP2024509332A5 (enExample) | ||
| JP2023548069A5 (enExample) | ||
| CN111153988A (zh) | 广谱抗肠道病毒d68型的中和性单克隆抗体 |